Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study has been designed to conduct as Randomized comparative clinical study.
Two groups, group B received Qurse Mafasil tablet orally two tablets two times daily for 8 weeks while group A received Leech therapy once weekly for 8 weeks along with Qurse mafasil.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group A | Experimental | Hirudinaria granulosa and Qurse mafasil are given |
|
| Group B | Active Comparator | Qurse mafasil only given |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hirudinaria granulosa, qurse mafasil | Biological | compare the efficacy of both groups |
|
| Measure | Description | Time Frame |
|---|---|---|
| KOOS Score | end of 6 weeks | |
| VAS | end of 6 weeks | |
| Active Range of Motion | end of 6 weeks | |
| Knee circumference | end of 6 weeks | |
| 15 m walking time test | end of 6 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| KOOS subscores | end of 6 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020370 | Osteoarthritis, Knee |
| ID | Term |
|---|---|
| D010003 | Osteoarthritis |
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D024763 | Leeching |
| D004364 | Pharmaceutical Preparations |
| ID | Term |
|---|---|
| D013812 | Therapeutics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D012216 |
| Rheumatic Diseases |